In the CIA model, the dual blockade of TNF and IL-17 gave better results than either monotherapy (106) and in the TNFα transgenic animal model of arthritis, as well as cartilage and bone damage, were better controlled with bi-specific antibodies (anti-TNFα and anti–IL-17A) than with monotherapies (100). Here, IL17A is linked to Arthritis.